AI assistant
Body and Mind Inc. — Earnings Release 2021
Nov 16, 2021
46462_rns_2021-11-15_9fc993f1-1f2b-486f-aff5-8e932d0f1ff5.pdf
Earnings Release
Open in viewerOpens in your device viewer
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8K
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November 15, 2021
Date of Report (Date of earliest event reported)
BODY AND MIND INC.
(Exact name of registrant as specified in its charter)
Nevada
(State or other jurisdiction of incorporation)
750 – 1095 West Pender Street Vancouver, British Columbia, Canada
(Address of principal executive offices)
00055940
(Commission File Number)
981319227
(IRS Employer Identification No.)
V6E 2M6
(Zip Code)
(800) 3616312
Registrant’s telephone number, including area code
Not applicable.
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
-
☐ Soliciting material pursuant to Rule 14a12 under the Exchange Act (17 CFR 240.14a12)
-
☐ Precommencement communications pursuant to Rule 14d2(b) under the Exchange Act (17 CFR 240.14d2(b))
-
☐ Precommencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | TradingSymbol(s) | Name of each exchange on which registered |
|---|---|---|
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (Section 230.405 of this chapter) or Rule 12b2 of the Securities Exchange Act of 1934 (Section 240.12b2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
SECTION 7 – REGULATION FD
Item 7.01 Regulation FD Disclosure
On November 15, 2021, Body and Mind Inc. (the “ Company ” or “ BaM” ) issued a news release to report Body and Mind branded products are available in Ohio and provide an update on operations in Michigan and Arkansas.
FY2021 Year End Financials
The Company anticipates reporting FY2021 (period ending July 31, 2021) year end financials on or before Thursday November 18[th] . The Company has an earnings call scheduled for Friday, November 19[th] and please see conference call dial in details at the end of this release.
Body and Mind Expands Branded Products to Ohio
The new Ohio processing facility is located next to the Body and Mind dispensary west of Cleveland and has been designed to produce popular Body and Mind concentrates using hydrocarbon extraction as well as edibles and oils. “We are excited to have the first of many SKU’s in the Ohio market as our team brings years of experience with a wide range of hydrocarbon extraction products,” stated Michael Mills, CEO of Body and Mind. “We designed the production facility as a topoftheline hydrocarbon facility to give the largest breadth of extraction products and we are in the process for approval of a full range of products to service the growing Ohio medical market. As early entrants to the Ohio market, our team has a deep understanding of consumer trends in the state and we look forward to the addition of our award winning concentrates, oils and edibles.”
Michigan Development
The Body and Mind dispensary in Muskegon, Michigan is moving quickly through renovation of a preexisting bank building located on a well trafficked thoroughfare with significant parking. The Company has hired a general manager for the location and training has commenced. The Body and Mind branded dispensary is anticipated to be operational in late 2021 or early 2022.
The Company has received building permits for phase 1 of the cultivation and production facility and is in the final stages of contractor selection and ordering long lead items. The cultivation and production facilities have received local approval and state preapproval for a 25,000 square foot cultivation and 5,000 square foot production facilities within the same existing building. The Company anticipates commencing construction shortly with construction plans for 25,000 square feet of cultivation to be built in phase 2.
Arkansas Cultivation
Comprehensive Care Group and BaM have commenced the first cultivation harvest at the West Memphis location and anticipate Body and Mind branded flower to be available in Arkansas before the end of November. “We are excited to bring Body and Mind quality flower to the state of Arkansas and look forward to producing many new strains in the near future,” stated Trip Hoffman, COO of Body and Mind. The cultivation facility is designed to produce enough flower to supply the Body and Mind dispensary as well as generate revenue from wholesales.
2
FY2021 Year End Conference Call Details
The Company will be hosting earnings call on Friday, November 19th, 2021 at 11:00 a.m. Eastern.
Participants can dial 18886646392 or 4167648659 and use confirmation number 13970998.
A replay of the conference call will be available at 18883900541 until November 26, 2021. Please use replay number 970998 #
A copy of the news release is attached as Exhibit 99.1 hereto.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| (d) Exhibits | ||
|---|---|---|
| Exhibit | Description | |
| 99.1 | News Release dated November 15, 2021. |
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BODY AND MIND INC. DATE: November 15, 2021 By: /s/ Michael Mills Michael Mills President, CEO and Director
4
EXHIBIT 99.1
==> picture [93 x 51] intentionally omitted <==
NEWS RELEASE – For Immediate Dissemination
Body and Mind Expands Branded Products to Ohio
Update on Michigan Development, Arkansas Cultivation and FY2021 Financials
LAS VEGAS, NV and VANCOUVER, B.C., CANADA (November 15, 2021) – Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) (the “Company” or “BaM” ), a multistate operator focused on limited license markets, is pleased to report Body and Mind branded products are available in Ohio and provide an update on operations in Michigan and Arkansas.
FY2021 Year End Financials
The Company anticipates reporting FY2021 (period ending July 31, 2021) year end financials on or before Thursday November 18[th] . The Company has an earnings call scheduled for Friday, November 19[th] and please see conference call dial in details at the end of this release.
Body and Mind Expands Branded Products to Ohio
The new Ohio processing facility is located next to the Body and Mind dispensary west of Cleveland and has been designed to produce popular Body and Mind concentrates using hydrocarbon extraction as well as edibles and oils. “We are excited to have the first of many SKU’s in the Ohio market as our team brings years of experience with a wide range of hydrocarbon extraction products,” stated Michael Mills, CEO of Body and Mind. “We designed the production facility as a topoftheline hydrocarbon facility to give the largest breadth of extraction products and we are in the process for approval of a full range of products to service the growing Ohio medical market. As early entrants to the Ohio market, our team has a deep understanding of consumer trends in the state and we look forward to the addition of our award winning concentrates, oils and edibles.”
Michigan Development
The Body and Mind dispensary in Muskegon, Michigan is moving quickly through renovation of a preexisting bank building located on a well trafficked thoroughfare with significant parking. The Company has hired a general manager for the location and training has commenced. The Body and Mind branded dispensary is anticipated to be operational in late 2021 or early 2022.
The Company has received building permits for phase 1 of the cultivation and production facility and is in the final stages of contractor selection and ordering long lead items. The cultivation and production facilities have received local approval and state preapproval for a 25,000 square foot cultivation and 5,000 square foot production facilities within the same existing building. The Company anticipates commencing construction shortly with construction plans for 25,000 square feet of cultivation to be built in phase 2.
Arkansas Cultivation
Comprehensive Care Group and BaM have commenced the first cultivation harvest at the West Memphis location and anticipate Body and Mind branded flower to be available in Arkansas before the end of November. “We are excited to bring Body and Mind quality flower to the state of Arkansas and look forward to producing many new strains in the near future,” stated Trip Hoffman, COO of Body and Mind. The cultivation facility is designed to produce enough flower to supply the Body and Mind dispensary as well as generate revenue from wholesales.
FY2021 Year End Conference Call Details
The Company will be hosting earnings call on Friday, November 19th, 2021 at 11:00 a.m. Eastern.
Participants can dial 18886646392 or 4167648659 and use confirmation number 13970998.
A replay of the conference call will be available at 18883900541 until November 26, 2021. Please use replay number 970998 #
About Body and Mind Inc.
BaM is an operations focused multistate operator investing in high quality medical and recreational cannabis cultivation, production and retail. Our wholly owned Nevada subsidiary was awarded one of the first medical marijuana cultivation licenses and holds cultivation and production licenses. BaM products include dried flower, edibles, oils and extracts as well as GPEN Gio cartridges. BaM cannabis strains have won numerous awards including the 2019 Las Vegas Weekly Bud Bracket, Las Vegas Hempfest Cup 2016, High Times Top Ten, the NorCal Secret Cup and the Emerald Cup.
BaM continues to expand operations in Nevada, California, Arkansas, Ohio and Michigan and is dedicated to increasing shareholder value by focusing resources on improving operational efficiencies, facility expansions, state licensing opportunities as well as mergers and acquisitions.
Please visit www.bodyandmind.com for more information. Instagram: @bodyandmindBaM Twitter: @bodyandmindBaM
For further information, please contact:
Investor Relations
Jonathan Paterson +1 203 862 0492 [email protected]
Company Contact:
Michael Mills CEO Tel: 8003616312 [email protected]
Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for the statements of historical fact contained herein, the information presented in this news release constitutes “forwardlooking statements” as such term is used in applicable United States and Canadian laws. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any other statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved) are not statements of historical fact and should be viewed as “forwardlooking statements”. Such forwardlooking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forwardlooking statements. Such risks and other factors include, among others, the actual results of activities, variations in the underlying assumptions associated with the estimation of activities, the availability of capital to fund programs and the resulting dilution caused by the raising of capital through the sale of shares, accidents, labor disputes and other risks. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forwardlooking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forwardlooking statements contained in this news release and in any document referred to in this news release.
Certain matters discussed in this news release and oral statements made from time to time by representatives of the Company may constitute forwardlooking statements. Although the Company believes that the expectations reflected in such forwardlooking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. Forwardlooking information is subject to certain risks, trends and uncertainties that could cause actual results to differ materially from those projected. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement any forwardlooking statements whether as a result of new information, future events or otherwise. This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities.